BioNeutral Group, Inc. and Barnabas Health in West Orange, N.J., jointly announce a collaborative research and revenue sharing agreement. The parties will develop protocols to trial Ygiene 206, a detergent cleaner, 90-second disinfectant and 20-minute sterilant. In addition, they will test new formulations designed for rapid cleaning and sterilization of surgical instruments, scopes, fabric and skin at Barnabas Health facilities.
Barnabas Health is the largest nonprofit integrated healthcare delivery system in New Jersey and one of the largest in the nation, treating more than two 2 million patients annually. The system includes 50 facilities with six acute-care hospitals, two children's hospitals, a behavioral health center, ambulatory care centers, surgery centers, breast and imaging centers, the state's largest behavioral health network, and comprehensive home care and hospice programs.
"We are excited to have access to world-first technology," says Barry H. Ostrowsky, president and CEO of Barnabas Health. "We see our role as being at the forefront of excellent care, utilizing the best tools available. Under the terms of the agreement, we will help develop new applications for the technology and Barnabas Health will have the first right to publish the data being generated. Barnabas Health will share in the commercial success produced by this collaboration."
"It is very important for technology-based companies like Bioneutral to engage with major healthcare providers to develop the best protocols for use and the data to demonstrate efficacy for the healthcare sector," says Andy Kielbania, CEO of Bioneutral Group, Inc. "Technology is a key factor in creating efficiencies which will drive down cost, mitigate risks and protect patients, staff and the public."
Nancy Chobin, RN, CSPDM, has been chosen as the principal researcher/investigator and, in conjunction with the Infection Prevention Department at Saint Barnabas Medical Center, will approve the protocols for testing and supervise the test process and the collection of data. Chobin is nationally recognized as a leader in the field of infection prevention and sterilization.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.